Rhythm has been targeted in a cyberattack that resulted in the theft of information and hackers asking for a ransom.
The U.S. Food and Drug Administration has issued a warning letter to iRhythm Technologies after inspectors found fault with practices at a facility that makes its heart monitors. According to iRhythm, ...
With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says
On Monday, the FDA approved iRhythm Technologies, Inc.’s (NASDAQ:IRTC) 510(k) submission related to prior design changes to the Zio AT device via letter to file. Zio AT remains commercially available ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Editor's Note: An earlier version misstated that iRhythm had not responded; the company provided a statement on Aug. 18. The short-seller argued that investors are overlooking regulatory, competitive, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results